{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:43:48Z","timestamp":1781685828489,"version":"3.54.5"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02055","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T13:57:43Z","timestamp":1599832663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["COVID-19: Infection or Autoimmunity"],"prefix":"10.3389","volume":"11","author":[{"given":"Timothy","family":"Icenogle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"B1","year":"2020","journal-title":"COVID-19 Data in Motion."},{"key":"B2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention.","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China.","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China.","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0191-1","article-title":"Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.","volume":"5","author":"Catanzaro","year":"2020","journal-title":"Sig Transduct Target Ther."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-23957\/v1","article-title":"Marked T cell activation, senescence, exhaustion and skewing towardsTH17 in patients with COVID-19 pneumonia.","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-COV-2 pneumonia in Wuhan, China: a single-centered retrospective, observational study.","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID- 19 associated with acute respiratory distress syndrome.","volume":"8","author":"Xu","year":"2020","journal-title":"Lance Respir Med."},{"key":"B10","first-page":"168","article-title":"Clinical characteristics predicting progression of COVID-19.","volume":"59","author":"Dong","year":"2020","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/1658-5127.155168","article-title":"Is secondary hemophagocytic lymphohistiocytosis behind the high fatality rate in Middle East respiratory syndrome corona virus?","volume":"6","author":"Al-Ahmari","year":"2015","journal-title":"J Appl Hematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(03)13413-7","article-title":"Lung pathology of fatal severe acute respiratory syndrome.","volume":"361","author":"Nicholls","year":"2003","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3201\/eid1003.030571","article-title":"Patient data early SARS epidemic, Taiwan.","volume":"10","author":"Hsueh","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B14","first-page":"656","article-title":"Lung pathology and the pathogenesis of severe acute respiratory syndrome: a report of six full autopsies.","volume":"24","author":"Pei","year":"2005","journal-title":"Zhonghua Bing Li Xue Za Zhi."},{"key":"B15","first-page":"183","article-title":"Severe acute respiratory syndrome (SARS)\u2013new, unknown disease?","volume":"16","author":"Zajkowska","year":"2004","journal-title":"Pol Merkur Lekarski."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"HLH across specialty collaboration, correspondence COVID-19: consider cytokine storm syndromes and immunosuppression.","volume":"6736","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management.","volume":"5","author":"George","year":"2014","journal-title":"J Blood Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/1097-0142(197909)44:3<993::AID-CNCR2820440329>3.0.CO;2-5","article-title":"Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.","volume":"44","author":"Risdall","year":"1979","journal-title":"Cancer."},{"key":"B21","author":"McClain","year":"2020","journal-title":"Clinical Features and Diagnosis of Hemophagocytic Lymphohistiocytosis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.bbmt.2009.11.014","article-title":"Histocytic disorders: recent insights into pathophysiology and practical guidelines.","volume":"16","author":"Filipovich","year":"2010","journal-title":"Bio Blood Marrow Transplant."},{"key":"B23","first-page":"1324","article-title":"Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systemic review.","volume":"16","author":"Cascio","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8 T cells and interferon gamma are essential for the disorder.","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157407","article-title":"Enhanced Th1\/Th17 Functions of CD161+ CD8+ T Cells in mucosal tissues of rhesus macaques.","volume":"11","author":"Rout","year":"2016","journal-title":"PLoS One."},{"key":"B26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl Sci Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type III interferons \u2013 induction, signaling, evasion, and application to combat COVID-19.","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104791","article-title":"Type 1 interferons as a potential treatment against COVID-19.","volume":"178","author":"Sallard","year":"2020","journal-title":"Antiviral Res."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa453","article-title":"Weak induction of interferon expression by SARS-CoV-2 supports clinical trials of interferon lambda to treat early COVID-19.","author":"Obrien","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19.","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"Review HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B33","author":"McClain","year":"2020","journal-title":"Treatment and Prognosis of Hemophagocytic Lymphohistiocytosis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis.","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.22.20137273","article-title":"Effect of dexamethasone in hospitalized patients with COVID-19 \u2013 preliminary report.","author":"Horby","year":"2020","journal-title":"medRxiv"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics."},{"key":"B37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3324\/haematol.2018.198655","article-title":"Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy.","volume":"104","author":"Yoon","year":"2019","journal-title":"Haematologica."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61345-1","article-title":"Cytotoxic therapy for severe swine flu A\/H1N1.","volume":"376","author":"Henter","year":"2010","journal-title":"Lancet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy.","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies.","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu Rev Med."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","article-title":"The Immunology of macrophage activation syndrome.","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clim.2009.02.005","article-title":"Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin.","volume":"132","author":"Coca","year":"2009","journal-title":"Clin Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic.","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic: an observational cohort study.","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10374","article-title":"Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City.","volume":"8","author":"Cheung","year":"2020","journal-title":"JAMA."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.","volume":"8","author":"Whittaker","year":"2020","journal-title":"JAMA."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15412","article-title":"Spectrum of COVID-19 in Children.","author":"Ranabothu","year":"2020","journal-title":"Acta Paediatr."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.05.117","article-title":"Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C).","author":"Greene","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/jpids\/piaa069","article-title":"Multisystem inflammatory syndrome in children during the COVID-19 pandemic: a case series.","volume":"9","author":"Chiotos","year":"2020","journal-title":"J Pediatr Infect Dis Soc."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.05.079","article-title":"Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases.","author":"Miller","year":"2020","journal-title":"Gastroenterology."},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.87a.ccc039","article-title":"New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response.","author":"Panupattanapong","year":"2020","journal-title":"Cleve Clin J Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"8386","DOI":"10.4049\/jimmunol.175.12.8386","article-title":"Cloning the arterial IgA antibody response during acute Kawasaki disease.","volume":"175","author":"Rowley","year":"2005","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-med-042409-151944","article-title":"Kawasaki Disease: novel insights into etiology and genetic susceptibility.","volume":"62","author":"Rowley","year":"2011","journal-title":"Annu Rev Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19).","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa190","article-title":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin.","author":"Hu","year":"2020","journal-title":"Eur Heart J."},{"key":"B57","first-page":"25","article-title":"Cardiac injury in patients with coronavirus disease 2019.","volume":"145","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019(COVID-19).","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system, a review.","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1105","article-title":"Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality.","author":"Bonow","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B61","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4049\/jimmunol.113.6.1726","article-title":"Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.","volume":"113","author":"Woodruff","year":"1974","journal-title":"J Immunol."},{"key":"B62","first-page":"681","article-title":"Lysis of infected myofibers by Coxsackie B-3 Immune T lymphocytes.","volume":"98","author":"Huber","year":"1980","journal-title":"Am J Pathol."},{"key":"B63","first-page":"21","article-title":"Coxsackie B-3 Myocarditis in Balb\/c Mice: evidence for autoimmunity to myocyte antigens.","volume":"116","author":"Huber","year":"1984","journal-title":"Am J Pathol."},{"key":"B64","first-page":"284","article-title":"Coxsackie B-3 myocarditis, identification of different pathogenic mechanisms in DBA\/2 and Balb\/c mice.","volume":"122","author":"Huber","year":"1986","journal-title":"Am J Pathol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91555-3","article-title":"Treatment of myocarditis with OKT3 monoclonal antibody.","volume":"1","author":"Gilbert","year":"1988","journal-title":"Lancet."},{"key":"B66","author":"Bilinska","year":"2007","journal-title":"Autoimmune Myocarditis: Treatment with Anti-T-Cell Antibodies. Immune Dysfunction and Immunotherapy in Heart Disease"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(04)90785-1","article-title":"Treatment of fulminant myocarditis with rabbit antithymocyte globulin: a pilot study.","author":"Icenogle","year":"2004","journal-title":"JACC."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.healun.2009.07.013","article-title":"Anti-thymocyte globulin as an adjunct to treatment of fulminant myocarditis.","volume":"28","author":"Manins","year":"2009","journal-title":"J Heart Lung Transplant."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond.","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia."},{"key":"B70","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/01.tp.0000295420.49063.b1","article-title":"Mechanisms of action of Thymoglobulin.","volume":"84","author":"Mueller","year":"2007","journal-title":"Transplantation."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/01.TP.0000164159.20075.16","article-title":"Polyclonal rabbit antithymocyte globulin triggers b-cell and plasma cell apoptosis by multiple pathways.","volume":"79","author":"Zand","year":"2005","journal-title":"Transplantation."},{"key":"B72","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/01.tp.0000200305.48244.a6","article-title":"In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia\/reperfusion in a primate model.","volume":"81","author":"Chappell","year":"2006","journal-title":"Transplantation."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1161\/CIR.0000000000000745","article-title":"Recognition and initial management of fulminant myocarditis, a scientific statement from the American Heart Association.","volume":"141","author":"Kociol","year":"2020","journal-title":"Circulation."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/TR.1000137","article-title":"Viral cardiomyopathy: a review of clinical status and meta-analysis of diagnosis and clinical management.","volume":"2","author":"Albakri","year":"2019","journal-title":"Trends Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.117.026386","article-title":"Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis.","volume":"136","author":"Ammirati","year":"2017","journal-title":"Circulation."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases.","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Hear J."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(87)90164-4","article-title":"Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens.","volume":"43","author":"Alvarez","year":"1987","journal-title":"Clin Immunol Immunopathol."},{"key":"B78","first-page":"566","article-title":"Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus.","volume":"69","author":"Neu","year":"1987","journal-title":"Clin Exp Immunol."},{"key":"B79","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.4049\/jimmunol.138.8.2488","article-title":"Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis.","volume":"138","author":"Neu","year":"1987","journal-title":"J Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1054-8807(01)00113-2","article-title":"Pathophysiology of viral myocarditis: the role of humoral immune response.","volume":"11","author":"Maisch","year":"2002","journal-title":"Cardiovasc Pathol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijcard.2014.10.165","article-title":"Passive transfer of affinity-purified anti-heart antibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice.","volume":"179","author":"Caforio","year":"2015","journal-title":"Int J Cardiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.RES.64.2.179","article-title":"Antibodies to the ADP\/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo.","volume":"69","author":"Schulze","year":"1989","journal-title":"Circ Res."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5301548","article-title":"Roles of host immunity in viral myocarditis and dilated cardiomyopathy.","volume":"2018","author":"Zhao","year":"2018","journal-title":"J Immun Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell.","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1600-6143.2007.02039.x","article-title":"Two novel assays of alloantibody secreting cells demonstrating resistance to desensitization with IVIG and rATG.","volume":"8","author":"Perry","year":"2008","journal-title":"Am J Transplant."},{"key":"B86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clim.2006.08.016","article-title":"Treatment with rituximab affects both the cellular and humoral arm of the immune system in patients with SLE.","volume":"122","author":"Vallerskog","year":"2007","journal-title":"Clin Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1073\/pnas.1001074107","article-title":"Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis.","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B88","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1600-6143.2006.01632.x","article-title":"The effect of desensitization protocol on human splenic B cell populations in vivo.","volume":"7","author":"Ramos","year":"2007","journal-title":"Am J Transplant."},{"key":"B89","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoblobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IGO2 trial.","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/0140-6736(93)92000-J","article-title":"Infusion of Fc\u03b3 fragments for treatment of children with acute immune thrombocytopenic pupura.","volume":"342","author":"Debre","year":"1993","journal-title":"Lancet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science."},{"key":"B92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1084\/jem.20061788","article-title":"The anti-inflammatory activity of IgG: the intravenous IgG paradox.","volume":"204","author":"Nimmerjahn","year":"2007","journal-title":"JEM."},{"key":"B93","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory action of intravenous immunoglobulin.","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.AC120.013788","article-title":"Inhibition of SARS-CoV-2 by type I and type III interferons.","author":"Felgenhauer","year":"2020","journal-title":"J Biol Chem."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.07.982264","article-title":"Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.","author":"Lokugamage","year":"2020","journal-title":"bioRxiv"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2020.107863","article-title":"Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells.","volume":"32","author":"Stanifer","year":"2020","journal-title":"Cell Rep."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104811","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 Infection.","volume":"179","author":"Mantlo","year":"2020","journal-title":"Antiviral Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Cytokine storm syndrome: looking toward the precision medicine era.","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02055\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T06:41:07Z","timestamp":1696660867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02055\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":98,"alternative-id":["10.3389\/fimmu.2020.02055"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02055","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"article-number":"2055"}}